CA1018890A - Comprimes de penicilline ou de cephalosporine et d'un carbonate de magnesium lourd - Google Patents

Comprimes de penicilline ou de cephalosporine et d'un carbonate de magnesium lourd

Info

Publication number
CA1018890A
CA1018890A CA198,938A CA198938A CA1018890A CA 1018890 A CA1018890 A CA 1018890A CA 198938 A CA198938 A CA 198938A CA 1018890 A CA1018890 A CA 1018890A
Authority
CA
Canada
Prior art keywords
cephalosporin
magnesium carbonate
tablets containing
orally active
pharmaceutical tablets
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA198,938A
Other languages
English (en)
Other versions
CA198938S (en
Inventor
Roger F. Haines-Nutt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beecham Group PLC
Original Assignee
Beecham Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group PLC filed Critical Beecham Group PLC
Application granted granted Critical
Publication of CA1018890A publication Critical patent/CA1018890A/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA198,938A 1973-05-05 1974-05-03 Comprimes de penicilline ou de cephalosporine et d'un carbonate de magnesium lourd Expired CA1018890A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB2150273A GB1422176A (en) 1973-05-05 1973-05-05 Pharmaceutical tablets
GB5685873 1973-12-07

Publications (1)

Publication Number Publication Date
CA1018890A true CA1018890A (fr) 1977-10-11

Family

ID=26255363

Family Applications (1)

Application Number Title Priority Date Filing Date
CA198,938A Expired CA1018890A (fr) 1973-05-05 1974-05-03 Comprimes de penicilline ou de cephalosporine et d'un carbonate de magnesium lourd

Country Status (10)

Country Link
JP (1) JPS5714649B2 (fr)
CA (1) CA1018890A (fr)
DE (1) DE2421273A1 (fr)
DK (1) DK145712C (fr)
FR (1) FR2227856B1 (fr)
GB (1) GB1422176A (fr)
IE (1) IE39216B1 (fr)
IL (1) IL44646A (fr)
NL (1) NL7406023A (fr)
SE (1) SE402405B (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2687233A1 (fr) * 2011-03-17 2014-01-22 Kyowa Chemical Industry Co., Ltd Liant destiné à la fabrication de comprimés

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH647676A5 (fr) * 1978-12-22 1985-02-15 Donald E Panoz Formes galeniques a usage oral, a liberation programmee et leurs procedes de preparation.
DE3239592C2 (de) * 1982-10-26 1986-10-30 Institut organičeskogo sinteza Akademii Nauk Latvijskoj SSR, Riga Antibakterielles Arzneimittel
EP0221699B1 (fr) * 1985-10-19 1990-01-10 Beecham Group Plc Composition pour le traitement des infections
US5433959A (en) 1986-02-13 1995-07-18 Takeda Chemical Industries, Ltd. Stabilized pharmaceutical composition
US6749864B2 (en) 1986-02-13 2004-06-15 Takeda Chemical Industries, Ltd. Stabilized pharmaceutical composition
CA1327010C (fr) * 1986-02-13 1994-02-15 Tadashi Makino Compositions pharmaceutiques contenant un compose anti-ulcereux de type benzimidazole et sa production
US4743450A (en) * 1987-02-24 1988-05-10 Warner-Lambert Company Stabilized compositions
GB9613470D0 (en) 1996-06-27 1996-08-28 Ciba Geigy Ag Small solid oral dosage form
IS7724A (is) * 2005-03-02 2006-09-03 Actavis Group Samsetning á töflum með hraða sundrun sem innihalda þungt magnesíum karbónat
EP1728511A1 (fr) * 2005-05-31 2006-12-06 Faust Pharmaceuticals Nouvelle utilisatIon de la phenethicilline
EP2531178B1 (fr) * 2010-02-03 2014-06-04 Merck Patent GmbH Carbonate d'hydroxyde de magnésium compressible par voie direct

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2687233A1 (fr) * 2011-03-17 2014-01-22 Kyowa Chemical Industry Co., Ltd Liant destiné à la fabrication de comprimés
EP2687233A4 (fr) * 2011-03-17 2014-11-19 Kyowa Chem Ind Co Ltd Liant destiné à la fabrication de comprimés

Also Published As

Publication number Publication date
DE2421273A1 (de) 1974-11-14
DK145712C (da) 1983-07-25
JPS5714649B2 (fr) 1982-03-25
IL44646A (en) 1977-04-29
FR2227856B1 (fr) 1978-02-03
NL7406023A (fr) 1974-11-07
GB1422176A (en) 1976-01-21
JPS5029732A (fr) 1975-03-25
IE39216L (en) 1974-11-05
DK145712B (da) 1983-02-07
SE402405B (sv) 1978-07-03
AU6853574A (en) 1975-11-06
IE39216B1 (en) 1978-08-30
IL44646A0 (en) 1974-06-30
FR2227856A1 (fr) 1974-11-29

Similar Documents

Publication Publication Date Title
AU472456B2 (en) Pharmacologically active compounds
AU465803B2 (en) Pencillin and cephalosporin compounds
CA1018890A (fr) Comprimes de penicilline ou de cephalosporine et d'un carbonate de magnesium lourd
AU473158B2 (en) Pharmacologically active compounds
AU475493B2 (en) Pharmaceutical formulations
AU473752B2 (en) Pharmacologically active compounds
AU466461B2 (en) Pharmaceutical preparations of penicillin compounds for rectal use
AU470538B2 (en) Magnesium capsules
CA1006157A (en) Penicillin derivatives
AU476390B2 (en) Pharmaceutical composition
CA997243A (en) Granulation of materials
CA940452A (en) Pharmaceutical tablet
CA975297A (en) Pharmaceutical composition containing a high percentage of allopurinol
CA986098A (en) Penicillin and cephalosporin derivatives
CA914164A (en) Penicillin and cephalosporin derivatives
AU480426B2 (en) Pharmaceutical tablets
CA969477A (en) Pharmaceutical preparation containing analgetic compounds and psychopharmacologically active compounds
CA816715A (en) Orally active cephalosporin antibiotics
CA905295A (en) Pharmaceutical compositions containing o-carbamyl-d-serine and cycloserine
CA988518A (en) Medicine comprising the benzilic ester of (dimethyl-2',5'pyrrolidino) -2-ethanol
AU477504B2 (en) -carboxy-2-thienylmethyl penicillin and cephalosporin and esters and salts thereof
CA834727A (en) Penicillin and cephalosporin derivatives
AU7439174A (en) 2-oxo-1-pyridinyl penicillin and cephalosporin derivatives
AU7438874A (en) 4-oxo-l-PYRIDINYL PENICILLIN AND CEPHALOSPORIN DERIVATIVES
CA961486A (en) Pharmaceutical compounds